On-treatment change in bone turnover markers predicts 2-year bone mineral density after sequential therapy following romosozumab: a real-world cohort study - Quiz - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Change in Bone Turnover Markers During Treatment as a Predictor of Two-Year Bone Mineral Density Following Sequential Romosozumab Therapy: Insights from a Real-World Cohort Study

  • By

  • Ryo Nakano

  • Ayumi Ichisawa

  • Kenya Saruta

  • Masakazu Kogawa

  • Akira Fukuda

  • June 17, 2026

Share

Original Source(s)

Related Content